The prognostic value of POD24 in relapsed/refractory follicular lymphoma—A SCHOLAR‐5 analysis
This study demonstrates that among patients with R/R FL initiating a ≥3rd LoT, POD24 patients reach these LoTs sooner after diagnosis and POD24 remains prognostic of subsequent OS. This suggests that POD24 status can inform clinical decision making in this population.
Authors
- Paola Ghione (ORCID: https://orcid.org/0000-0001-6986-7954)
- Eve H. Limbrick‐Oldfield (ORCID: https://orcid.org/0000-0001-5400-8030)
- Markqayne D Ray
- Steve Kanters (ORCID: https://orcid.org/0000-0003-0322-5398)
- John G. Gribben (ORCID: https://orcid.org/0000-0002-8505-7430)
- Timothy Best
- Anik R. Patel (ORCID: https://orcid.org/0000-0001-9091-8904)
- Sara Beygi (ORCID: https://orcid.org/0000-0002-2221-4320)
- Madhu Palivela
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Barts Health NHS Trust (GB)
Publication Details
- Journal
- eJHaem
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/jha2.1104
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00